MadeGood recalls granola bars over possible metal contamination
Listen to article
In a wave of recent food recalls, consumers are once again urged to check their snacks. MadeGood granola bars, sold across the US, Canada, and international markets, have been voluntarily recalled due to potential contamination. Here's what you need to know about the recall and how to stay safe.
Why were MadeGood granola bars recalled?
Riverside Natural Foods, the Canadian manufacturer of MadeGood products, issued a voluntary recall on December 9, 2024, pulling 2,408,883 cases from store shelves. The recall was prompted by concerns over the possible presence of metal in certain granola bars. On February 11, the US Food and Drug Administration (FDA) classified it as a Class II recall, indicating a potential health risk.
MadeGood's statement on the tecall
In a news release, the company explained:
"We are voluntarily recalling certain MadeGood granola bars as a precautionary measure due to a potential safety hazard. There is a very small risk that some of our granola bars, produced between January and November 2024, may contain a piece of metal. We have identified and resolved the source of the issue and are conducting this recall in cooperation with regulatory authorities. No injuries have been reported, but we are taking this step out of an abundance of caution and commitment to customer safety."
Which MadeGood granola bars are affected?
The recall includes several popular flavors, such as:
Chocolate Chip Granola Bars
Mixed Berry Granola Bars
Strawberry Granola Bars
Cookies & Crème Granola Bars
Chocolate Banana Granola Bars
Chocolate Drizzled Birthday Cake Granola Bars
Chocolate Drizzled Cookie Crumble Granola Bars
Chocolate Drizzled Vanilla Granola Bars
Consumers can check the full list of affected UPCs and best-by dates on the MadeGood website. Items marked with a "Z" after the best-by date are not included in the recall. The recalled products were distributed through major retailers, including Amazon, Target, Whole Foods, Wegmans, and CVS.
What Is the safety concern?
MadeGood clarified that the potential contaminant is a small, flat brush bristle, which they believe is highly unlikely to be present in most products. Despite selling hundreds of millions of bars, the company has received only a handful of reports regarding the issue.
What should consumers do?
If you have any of the recalled granola bars, discontinue use immediately and return them to the store for a refund. For more details, visit MadeGood's official
website or contact their customer service.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Express Tribune
15-02-2025
- Express Tribune
MadeGood recalls granola bars over possible metal contamination
Listen to article In a wave of recent food recalls, consumers are once again urged to check their snacks. MadeGood granola bars, sold across the US, Canada, and international markets, have been voluntarily recalled due to potential contamination. Here's what you need to know about the recall and how to stay safe. Why were MadeGood granola bars recalled? Riverside Natural Foods, the Canadian manufacturer of MadeGood products, issued a voluntary recall on December 9, 2024, pulling 2,408,883 cases from store shelves. The recall was prompted by concerns over the possible presence of metal in certain granola bars. On February 11, the US Food and Drug Administration (FDA) classified it as a Class II recall, indicating a potential health risk. MadeGood's statement on the tecall In a news release, the company explained: "We are voluntarily recalling certain MadeGood granola bars as a precautionary measure due to a potential safety hazard. There is a very small risk that some of our granola bars, produced between January and November 2024, may contain a piece of metal. We have identified and resolved the source of the issue and are conducting this recall in cooperation with regulatory authorities. No injuries have been reported, but we are taking this step out of an abundance of caution and commitment to customer safety." Which MadeGood granola bars are affected? The recall includes several popular flavors, such as: Chocolate Chip Granola Bars Mixed Berry Granola Bars Strawberry Granola Bars Cookies & Crème Granola Bars Chocolate Banana Granola Bars Chocolate Drizzled Birthday Cake Granola Bars Chocolate Drizzled Cookie Crumble Granola Bars Chocolate Drizzled Vanilla Granola Bars Consumers can check the full list of affected UPCs and best-by dates on the MadeGood website. Items marked with a "Z" after the best-by date are not included in the recall. The recalled products were distributed through major retailers, including Amazon, Target, Whole Foods, Wegmans, and CVS. What Is the safety concern? MadeGood clarified that the potential contaminant is a small, flat brush bristle, which they believe is highly unlikely to be present in most products. Despite selling hundreds of millions of bars, the company has received only a handful of reports regarding the issue. What should consumers do? If you have any of the recalled granola bars, discontinue use immediately and return them to the store for a refund. For more details, visit MadeGood's official website or contact their customer service.
Express Tribune
09-02-2025
- Express Tribune
FDA recalls 2 million baked goods over listeria risk
Listen to article The US Food and Drug Administration (FDA) has issued a recall for around 2 million baked goods, including various types of doughnuts, due to the risk of Listeria monocytogenes contamination. The recall affects 60 products manufactured by FGF Brands, a wholesale pastry supplier that distributes baked goods in the United States and Canada. According to the FDA, the affected products—produced before 13 December 2024—include flavoured and filled doughnuts, cinnamon sticks, French crullers, and fritters. Some of these were also sold at Dunkin'. Recall Classification and Consumer Advisory Initially announced on 7 January, the recall was upgraded to a Class II recall on Wednesday. Under FDA guidelines, this classification is applied when consuming the product could lead to temporary or medically reversible health effects, while the risk of severe consequences remains low. The FDA has not provided further instructions for consumers at this stage. FGF Brands has yet to comment on the recall. Customers can reach the company by phone at +1 905-761-3333 or via email at info@ A full list of affected products is available on the FDA's website. Risks of Listeria Contamination The bacterium Listeria monocytogenes can cause listeriosis, a serious foodborne infection. According to the Centers for Disease Control and Prevention (CDC), listeria is among the leading causes of death from foodborne illness in the US, with approximately 1,600 cases and 260 deaths reported annually. Symptoms of listeriosis include: Fever Muscle aches Headache Stiff neck Confusion Loss of balance Convulsions Diarrhoea and other gastrointestinal symptoms For pregnant women, infection can result in miscarriage, stillbirth, premature birth, or severe illness in newborns. Health authorities advise individuals in high-risk categories to seek medical attention if they develop flu-like symptoms within two months of consuming contaminated food.
Express Tribune
31-01-2025
- Express Tribune
FDA approves non-opioid pain medication as new alternative for pain relief
Listen to article The US Food and Drug Administration (FDA) has approved a new pain medication, suzetrigine, marking the first new type of pain reliever to be approved in over 20 years. The drug, sold under the brand name Journavx, is a 50-milligram prescription pill taken every 12 hours after an initial larger dose. This approval introduces a non-opioid analgesic option, offering a potential alternative to opioids, which are often associated with addiction and dependence. Dr. Jacqueline Corrigan-Curay, acting director of the FDA's Center for Drug Evaluation and Research, emphasized the importance of suzetrigine as a new pain management option. Suzetrigine works by blocking pain-signaling nerves around the body, preventing them from sending pain signals to the brain, unlike opioids, which affect the brain's perception of pain. This method aims to eliminate the risks linked to opioid use, such as euphoria and addiction. The development of suzetrigine was inspired by a family in Pakistan with a rare genetic mutation that prevents pain signals from firing, allowing them to walk on hot coals without pain. Researchers focused on the molecular mechanisms behind this phenomenon, leading to the creation of suzetrigine. The drug works by blocking a specific sodium channel responsible for conducting pain signals. In clinical trials, suzetrigine demonstrated effectiveness in managing pain after abdominal and foot surgeries, reducing pain by an average of 3.5 points on a scale of 0 to 10. However, its efficacy in treating chronic pain, such as sciatica, remains uncertain, as studies showed limited results compared to placebos. Despite this, Vertex Pharmaceuticals, the drug's developer, continues to explore its use for chronic pain conditions like diabetic neuropathy. Suzetrigine is now available at a wholesale cost of $15.50 per pill, with patient assistance programs to aid accessibility. The approval of suzetrigine is seen as a significant step forward in pain management, providing both physicians and patients with a new, potentially safer alternative to opioids. However, its success in the market will depend on insurance coverage and patient access.
